JONATHAN RAYBURN: Open Payments
NPI 1033537212 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 54 payments from 10 companies in 2025. Trend: 2023 $1,122 · 2024 $1,268 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 35 | $522 |
| Abbott Laboratories | 7 | $190 |
| Collegium Pharmaceutical, Inc. | 4 | $94 |
| Medtronic, Inc. | 2 | $41 |
| Stryker Corporation | 1 | $38 |
| SI-BONE, INC. | 1 | $32 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Valinor Pharma, LLC | 1 | $16 |
Products named: General - Therapies, PROCLAIM, Belbuca, General - Pain Management, ETERNA, INCEPTIV, MILD DEVICE KIT, ULTOMIRIS.
Industry payments across MS — which companies pay providers there.
